Core Scientific, Inc.
CORZQ · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $555 | $26 | $3,474 | $3,205 |
| - Cash | $50 | $16 | $118 | $9 |
| + Debt | $866 | $38 | $819 | $40 |
| Enterprise Value | $1,370 | $47 | $4,175 | $3,236 |
| Revenue | $502 | $640 | $544 | $60 |
| % Growth | -21.5% | 17.6% | 802.7% | – |
| Gross Profit | $123 | $8 | $239 | $9 |
| % Margin | 24.6% | 1.3% | 43.9% | 15.6% |
| EBITDA | $114 | -$211 | $184 | $12 |
| % Margin | 22.8% | -32.9% | 33.8% | 19.8% |
| Net Income | -$246 | -$2,146 | $47 | -$12 |
| % Margin | -49.1% | -335.2% | 8.7% | -20.2% |
| EPS Diluted | -0.644 | -6.3 | 0.15 | -0.039 |
| % Growth | 89.8% | -4,300% | 489.6% | – |
| Operating Cash Flow | $65 | $205 | -$57 | -$24 |
| Capital Expenditures | -$17 | -$602 | -$425 | -$15 |
| Free Cash Flow | $48 | -$396 | -$481 | -$39 |